In Singapore, high-risk drugs undergo a stringent evaluation by the Health Sciences Authority (HSA). The process includes pre-submission consultations, scientific assessments, and clinical data reviews. The HSA ensures safety, efficacy, and quality through rigorous testing and post-market surveillance, adhering to international standards to protect public health and safety.